Lilly Is Not ‘Feeling the Bern’ on Drug Prices Like Novo: Why the Double Standard?

Sen. Bernie Sanders’ aggressive targeting of Danish drugmaker Novo Nordisk’s Ozempic and Wegovy pricing, and not Eli Lilly’s rival drugs, is not fair.